
DNA vs RGNX
$DNA vs $RGNX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
DNA vs RGNX: the quick read
- ·RGNX is the larger company by market cap ($527M vs $450M).
- ·DNA has been more active on our scanner (131 vs 122 alerts in 30 days).
- ·RGNX has the smaller float (58.1M vs 62.0M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 131 and 122 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 17% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: DNA is outperforming the other by roughly 8.5 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing DNA and RGNX on TheDesperateTrader.
- Is DNA or RGNX the better stock?
- "Better" depends on your goal, and these two are not alike. RGNX is the larger company by market cap ($527M vs $450M). DNA has been more active on our scanner (131 vs 122 alerts in 30 days). RGNX has the smaller float (58.1M vs 62.0M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between DNA and RGNX?
- The differences that matter: they are similar in size ($450M vs $527M); they trade at very different share prices ($7.80 vs $8.14); DNA sits at 20% of its 52-week range against 25% for RGNX; our scanner flagged DNA 131 times in the last 30 days against 122 for RGNX. Everything above is measured from the latest completed session and SEC filings.
- Which of DNA and RGNX is more active right now?
- Right now DNA is at about 0.8x its normal volume and RGNX is at about 1.0x, so RGNX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading DNA or RGNX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore DNA and RGNX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.